BPBenedetta Pongiglione

Benedetta Pongiglione

*This is an algorithmically generated author record based on publicly available information.

Benedetta Pongiglione has a total of 88 co-authors. Here are the top co-authors by number of shared publications:

  • Aleksandra Torbica

    Centre for Research on Health and Social Care Management (CERGAS) Bocconi University Milan Italy

    6 shared publications
  • Bianca Lucia De Stavola

    Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, United Kingdom

    4 shared publications
  • George B. Ploubidis

    Centre for Longitudinal Studies, University College London, London, UK

    3 shared publications
  • Alessandra Angelucci

    Dipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milano, Italy

    2 shared publications
  • Daniela Di Cuonzo

    Unit of Clinical Epidemiology, San Giovanni Battista Hospital, CPO-Piemonte and University of Turin, Via Santena 7, 10126, Torino, Italy

    2 shared publications
  • Eva Pagano

    Unit of Clinical Epidemiology, San Giovanni Battista Hospital, CPO-Piemonte and University of Turin, Via Santena 7, 10126, Torino, Italy

    2 shared publications

Latest Publications

  • Improved accessibility and long-term effects of clinical networks: A mixed methods analysis of the implementation journey of a mature cancer network in Italy

    by Valeria D. Tozzi, Paola Roberta Boscolo, Lucia Ferrara, Oscar Bertetto, Anna Castiglione, Giovannino Ciccone, Daniela Di Cuonzo, Gianpiero Fasola, Marco Gilardetti, Eva Pagano, et al.

  • Open Access

    Assessing clinical networks through evidence: an empirical analysis of the effectiveness of cancer networks in improving patients’ quality of care and survival

    by Rosanna Tarricone, Benedetta Pongiglione, Paola Roberta Boscolo, Valeria Tozzi, Anna Castiglione, Eva Pagano, Daniela Di Cuonzo, Marco Gilardetti, Gianpiero Fasola, Oscar Bertetto, et al.

  • Open Access

    Improvement of medication adherence in osteoporosis through telemedicine combined with email: a patient-reported experience and outcome measure-based prospective study

    by Gherardo Mazziotti, Benedetta Pongiglione, Flaminia Carrone, Michela Meregaglia, Alessandra Angelucci, Maria Laura Costantino, Andrea Aliverti, Andrea Gerardo Antonio Lania, Amelia Compagni

    Objectives: To evaluate whether adherence to oral bisphosphonate in patients with osteoporosis may be improved by teleconsultation (TC) with or without combined use of email to contact the bone specialist on-demand (enhanced TC). Methods: 103 naïve patients with osteoporosis were prescribed branded alendronate (70 mg weekly) and randomised to three service modalities (presence, TC and enhanced TC), and evaluated for medication adherence after 12 months of follow-up. Patients allocated to the enhanced TC were provided with the opportunity to contact the bone specialists by email without any restriction. Patient-reported outcome(PROMs) and experience measures (PREMs) were evaluated with respect to the service modality. Results: Of 89 patients who were persistent to therapy, 66% displayed optimal medication adherence, with odds being 4.5 higher in patients receiving enhanced TC versus those receiving the other services. TC service modality was considered in general to be worse in quality than in presence visits, whereas the combination with email use as in enhanced TC was sufficient to compensate for the perceived decrease in quality of care. Enhanced TC did not have any impact on the perception of quality of life as assessed by PROMs. Discussion: In patients with osteoporosis, TC did not provide any advantage over traditional in presence visits in terms of improvement of adherence to therapy. However, when TC was combined with email to contact the bone specialist on demand, there was a significant improvement in adherence to the prescribed drug. Conclusions: Patients with osteoporosis need to be supported after drug prescription to guarantee optimal medication therapy.


  • Open Access

    III Rapporto - Dopo la laurea: gli sbocchi occupazionali dei laureati milanesi e lombardi

    by Fabio Mercorio, Mario Mezzanzanica, Antonio Serino, Andrea Seveso, Marina Timoteo, Claudia Girotti, Sara Binassi, Silvia Figini, Simone Gerzeli, Benedetta Pongiglione, et al.

    Il Terzo Rapporto MHEO analizza le dinamiche occupazionali dei laureati lombardi, con focus sulle transizioni tra università e lavoro. Utilizzando dati delle Comunicazioni Obbligatorie e indagini AlmaLaurea, il rapporto esplora tempi e tipologie contrattuali di inserimento, mobilità territoriale e soddisfazione lavorativa. I primi tre capitoli approfondiscono le traiettorie dei laureati milanesi, gli esiti occupazionali in Lombardia e le richieste del mercato del lavoro regionale tramite il sistema Excelsior. Un quarto capitolo amplia lo sguardo all’Europa, indagando il ruolo strategico delle competenze STEM. L’analisi evidenzia criticità e opportunità, fornendo strumenti per rafforzare il dialogo tra formazione e mercato.

  • 3. Domanda di lavoro in Lombardia

    by Silvia Figini, Simone Gerzeli, Benedetta Pongiglione, Luca Morgantino

  • Open Access

    Excess hospitalizations and in-hospital mortality associated with seasonal influenza in Italy: a 11-year retrospective study

    by Giovanni Fattore, Benedetta Pongiglione, Luigi Vezzosi

    Background: Influenza and flu-like syndromes are difficult to monitor because the symptoms are not specific, laboratory tests are not routinely performed, and diagnosis codes are often lacking or incompletely registered in medical records. This may result in an underestimation of hospital admissions, associated costs, and in-hospital mortality. Therefore, this study aimed to estimate the public health and economic burden of hospitalisations associated with influenza in Italy, at the national and regional levels. Methods: This 11-year retrospective study included patients admitted to hospitals for influenza or diagnoses associated with influenza (including respiratory and cardiocirculatory conditions) from 2008/09 to 2018/19. Data on hospitalisations were extracted from the Italian Hospital Discharge Records. Information on weekly influenza-like syndrome incidence and weekly average temperature were used to estimate the burden of influenza in terms of hospital admissions in every Italian region and for different age groups by applying a negative binomial model. The model was also applied to estimate in-hospital mortality and the total costs of influenza and influenza-like hospital admissions. Results: Over the study period, in addition to 3,970 average seasonal admissions coded as influenza, we estimated an average of 21,500 excess hospitalization associated with influenza per season, which corresponds to 36.4 cases per 100,000. Most of the excess hospitalisations concerned older individuals (> 65 years) and children (0–4 years) with 86 and 125 cases per 100,000, respectively. Large variations were observed across regions. Overall, the total estimated hospital burden associated with influenza (including respiratory and cardiocirculatory conditions) was approximately €123 m per year. While the in-hospital mortality for admissions with a primary diagnosis of influenza was very low (~ 150 cases per season), cases increased dramatically for primary diagnoses of influenza and pneumonia (about 9,500 cases per season). The average seasonal in-hospital deaths attributable to influenza were equal to 2,775 cases. Conclusions: Our findings suggest a remarkable underestimation of the burden of influenza, mostly in the older population but not neglectable in younger individuals. Our results may aid the management of current and future flu seasons and should be used for policy making (e.g., vaccine strategies) and operation management choices (e.g., planning and staffing beds during influenza peaks). Overall, the present study supports the need for increased testing for influenza in Italy to tackle the current underestimation of influenza burden.


  • Open Access

    Excess hospitalizations and in-hospital mortality associated with seasonal influenza in Italy: a 11-year retrospective study

    by Giovanni Fattore, Benedetta Pongiglione, Luigi Vezzosi

    Background Influenza and flu-like syndromes are difficult to monitor because the symptoms are not specific, laboratory tests are not routinely performed, and diagnosis codes are often lacking or incompletely registered in medical records. This may result in an underestimation of hospital admissions, associated costs, and in-hospital mortality. Therefore, this study aimed to estimate the public health and economic burden of hospitalisations associated with influenza in Italy, at the national and regional levels. Methods This 11-year retrospective study included patients admitted to hospitals for influenza or diagnoses attributable to influenza (including respiratory and cardiocirculatory conditions) from 2008/09 to 2018/19. Data on hospitalisations were extracted from the Italian Hospital Discharge Records. Information on weekly influenza-like syndrome incidence and weekly average temperature were used to estimate the burden of influenza in terms of hospital admissions in every Italian region and for different age groups by applying a negative binomial model. The model was also applied to estimate in-hospital mortality and the total costs of influenza and influenza-like hospital admissions. Results Over the study period, in addition to 3,970 average seasonal admissions coded as influenza, we estimated an average of 21,500 admissions per season attributable to influenza, which corresponds to 36.4 cases per 100,000. Most of the estimated additional hospitalisations concerned older individuals (> 65 years) and children (0–4 years) with 86 and 125 cases per 100,000, respectively. Large variations were observed across regions. Overall, the total estimated hospital burden attributable to influenza (including respiratory and cardiocirculatory conditions) was approximately €132m per year. While the in-hospital mortality for admissions with a primary diagnosis of influenza was very low (∼150 cases per season), cases increased dramatically for primary diagnoses of influenza and pneumonia (about 9,500 cases per season). The average seasonal estimated in-hospital mortality for admissions attributable to influenza was equal to 2,775 cases. Conclusions Our findings suggest a remarkable underestimation of the burden of influenza, mostly in the older population but not neglectable in younger individuals. Our results may aid the management of current and future flu seasons and should be used for policy making (e.g., vaccine strategies) and operation management choices (e.g., planning and staffing beds during influenza peaks). Overall, the present study supports the need for increased testing for influenza in Italy to tackle the current underestimation of influenza burden.

  • Open Access

    Patient characteristics associated with the acceptability of teleconsultation: a retrospective study of osteoporotic patients post-COVID-19

    by Benedetta Pongiglione, Flaminia Carrone, Alessandra Angelucci, Gherardo Mazziotti, Amelia Compagni

    Background: Due to the COVID-19 pandemic, teleconsultations (TCs) have become common practice for many chronic conditions, including osteoporosis. While satisfaction with TCs among patients increases in times of emergency, we have little knowledge of whether the acceptability of TCs persists once in-person visits return to being a feasible and safe option. In this study, we assess the acceptability of TCs across five dimensions for osteoporosis care among patients who started or continued with TCs after the COVID-19 pandemic had waned. We then explore the patient characteristics associated with these perceptions. Methods: Between January and April 2022, 80 osteoporotic patients treated at the Humanitas Hospital in Milan, Italy, were recruited to answer an online questionnaire about the acceptability of TCs for their care. The acceptability of TCs was measured using a modified version of the Service User Technology Acceptability Questionnaire (SUTAQ), which identifies five domains of acceptability: perceived benefits, satisfaction, substitution, privacy and discomfort, and care personnel concerns. Multivariable ordinary least squares (OLS) linear regression analysis was performed to assess which patient characteristics in terms of demographics, socio-economic conditions, digital skills, social support, clinical characteristics and pattern of TC use were correlated with the five domains of acceptability measured through the SUTAQ. Results: The degree of acceptability of TCs was overall good across the 80 respondents and the five domains. Some heterogeneity in perceptions emerged with respect to TCs substituting for in-person visits, negatively impacting continuity of care and reducing the length of consultations. For the most part, acceptability was not affected by patient characteristics with a few exceptions related to treatment time and familiarity with the TC service modality (i.e., length of osteoporosis treatment and number of TCs experienced by the patient). Conclusions: TCs appear to be an acceptable option for osteoporosis care in the aftermath of the COVID-19 pandemic. This study suggests that other characteristics besides age, digital skills and social support, which are traditionally relevant to TC acceptability, should be taken into account in order to better target this care delivery modality.


  • Open Access

    Spillover effects and other determinants of medical device uptake in the presence of a medical guideline: An analysis of drug‐eluting stents in Germany and Italy

    by Meilin Möllenkamp, Benedetta Pongiglione, Stefan Rabbe, Aleksandra Torbica, Jonas Schreyögg

    We investigated the role of spillover effects among hospitals in the diffusion of drug‐eluting stents (DES) in Germany and Italy during a period in which the relevant medical guideline clearly recommended their use over bare‐metal stents. We used administrative data of hospitalized patients treated with ST‐elevation myocardial infarction from 2012 to 2016 to estimate spatial panel models allowing for global spillover effects. We used an inverse‐distance weights matrix to capture the geographical proximity between neighboring hospitals and assigned a lower weight to more distant neighbors. For both countries, we found significant positive spatial autocorrelation in most years based on the global Moran's I test, and a significant, positive spatial lag parameter across model specifications, indicating positive spillover effects among neighboring hospitals. We found that private for‐profit hospital ownership and hospital competition in Germany and the number of inpatient cases with circulatory system diseases in Italy were other significant determinants of DES adoption. Our results underline the importance of spillover effects among peers for the diffusion of medical devices even in the presence of a positive guideline recommendation. Policymakers might therefore consider promoting various forms of exchange and collaboration among medical staff and hospitals to ensure the appropriate use of medical technologies.


  • Open Access

    Real‐world evidence in health technology assessment of high‐risk medical devices: Fit for purpose?

    by Philip Klein, Hedwig Blommestein, Maiwenn Al, Benedetta Pongiglione, Aleksandra Torbica, Saskia de Groot

    Health technology assessment (HTA) of medical devices (MDs) increasingly rely on real‐world evidence (RWE). The aim of this study was to evaluate the type and the quality of the evidence used to assess the (cost‐)effectiveness of high risk MDs (Class III) by HTA agencies in Europe (four European HTA agencies and EUnetHTA), with particular focus on RWE. Data were extracted from HTA reports on the type of evidence demonstrating (cost‐)effectiveness, and the quality of observational studies of comparative effectiveness using the Good Research for Comparative Effectiveness principles. 25 HTA reports were included that incorporated 28 observational studies of comparative effectiveness. Half of the studies (46%) took important confounding and/or effect modifying variables into account in the design and/or analyses. The most common way of including confounders and/or effect modifiers was through multivariable regression analysis. Other methods, such as propensity score matching, were rarely employed. Furthermore, meaningful analyses to test key assumptions were largely omitted. Resulting recommendations from HTA agencies on MDs is therefore (partially) based on evidence which is riddled with uncertainty. Considering the increasing importance of RWE it is important that the quality of observational studies of comparative effectiveness are systematically assessed when used in decision‐making.